TLR4 and rheumatoid arthritis: The molecule blocks TLR4 activation and it has been shown that in several in vitro and in vivo models B. quintana LPS can be used as a potential therapeutic agent for the treatment of rheumatoid arthritis, ventilation-induced lung injury (VILI), atherosclerosis and other autoinflammatory diseases15, 23, 24, 25.